LS
FPRX

Lupo Securities’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Lupo Securities’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$29K Buy
1,880
+1,130
+151% +$24.3K 0.22% 43
2015
Q2 		$19K Sell
750
-550
-42% -$12.3K 0.08% 49
2015
Q1 		$30K Buy
+1,300
New +$32.8K 0.05% 190

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lupo Securities's FPRX Position: Q3 2015 in Review

Lupo Securities increased its Five Prime Therapeutics, Inc. (FPRX) stake by 151% in Q3 2015, buying an estimated $24.3K and bringing the position to 1,880 shares worth $29K. The position accounts for 0.22% of the portfolio, ranked #43.

Lupo Securities first reported a position in FPRX in Q1 2015 and has held it in 3 quarters since. The position peaked at $30K in Q1 2015. 111 funds tracked by Wall St. Rank hold FPRX as of Q3 2015.

  • Lupo Securities held 1,880 shares of Five Prime Therapeutics, Inc. worth $29K as of Q3 2015.
  • Lupo Securities bought 1,130 Five Prime Therapeutics, Inc. shares in Q3 2015, an estimated $24.3K.
  • Five Prime Therapeutics, Inc. made up 0.22% of Lupo Securities's portfolio in Q3 2015, its #43 holding.
  • Lupo Securities first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and has held it in 3 quarters since.
  • Lupo Securities's Five Prime Therapeutics, Inc. position peaked at $30K in Q1 2015.
  • 111 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.